ANXA2 and DYSF

Number of citations of the paper that reports this interaction (PubMedID 14506282)
146

Data Source:
HPRD (in vitro)

		ANXA2	DYSF
Description		annexin A2	dysferlin
Image
GO Annotations	Cellular Component	Ruffle Extracellular Region Basement Membrane Extracellular Space Cell Nucleus Cytoplasm Lysosomal Membrane Endosome Early Endosome Lipid Droplet Cytosol Plasma Membrane Adherens Junction Cell Cortex Cell Surface Membrane Basolateral Plasma Membrane Extrinsic Component Of Plasma Membrane Midbody Late Endosome Membrane Vesicle Azurophil Granule Lumen Myelin Sheath Adaxonal Region Sarcolemma Melanosome Schmidt-Lanterman Incisure Macropinosome Membrane Raft Perinuclear Region Of Cytoplasm Collagen-containing Extracellular Matrix Extracellular Exosome AnxA2-p11 Complex PCSK9-AnxA2 Complex	Nucleus Endosome Early Endosome Late Endosome Golgi Apparatus Microtubule Plasma Membrane Integral Component Of Membrane Lamellipodium Endocytic Vesicle T-tubule Cytoplasmic Vesicle Membrane Cytoplasmic Vesicle Centriolar Satellite Sarcolemma Extracellular Exosome Membrane Microdomain
	Molecular Function	Phosphatidylserine Binding Protease Binding RNA Binding Calcium Channel Activity Calcium Ion Binding Protein Binding Calcium-dependent Phospholipid Binding Phosphatidylinositol-4,5-bisphosphate Binding Cytoskeletal Protein Binding Rab GTPase Binding Phospholipase A2 Inhibitor Activity Identical Protein Binding S100 Protein Binding Virion Binding Calcium-dependent Protein Binding Cadherin Binding Involved In Cell-cell Adhesion Molecular Function Regulator	Calcium Ion Binding Protein Binding Phospholipid Binding Calcium-dependent Phospholipid Binding Microtubule Binding Alpha-tubulin Binding
	Biological Process	Angiogenesis Membrane Raft Assembly Positive Regulation Of Receptor Recycling Vesicle Budding From Membrane Body Fluid Secretion Viral Process Positive Regulation Of Vesicle Fusion Negative Regulation Of Low-density Lipoprotein Particle Receptor Catabolic Process Interleukin-12-mediated Signaling Pathway Osteoclast Development Negative Regulation Of Catalytic Activity Neutrophil Degranulation Positive Regulation Of Vacuole Organization Negative Regulation Of Development Of Symbiont Involved In Interaction With Host Regulation Of Cytosolic Calcium Ion Concentration Catabolism By Host Of Symbiont Protein Negative Regulation By Host Of Symbiont Molecular Function Calcium Ion Transmembrane Transport Response To Thyroid Hormone Cell-cell Adhesion Positive Regulation Of Low-density Lipoprotein Particle Clearance Positive Regulation Of Low-density Lipoprotein Particle Receptor Binding Positive Regulation Of Low-density Lipoprotein Receptor Activity Positive Regulation Of Receptor-mediated Endocytosis Involved In Cholesterol Transport	Angiogenesis Plasma Membrane Repair Positive Regulation Of Endothelial Cell Proliferation Monocyte Activation Involved In Immune Response Macrophage Activation Involved In Immune Response Glycerol Metabolic Process Vesicle Fusion Muscle Contraction Plasma Membrane Organization Negative Regulation Of Gene Expression Lipid Storage T-tubule Organization Negative Regulation Of Protein Catabolic Process Skeletal Muscle Tissue Regeneration Fat Cell Differentiation Positive Regulation Of Cell Adhesion Muscle Fiber Development Cytokine Secretion Negative Regulation Of Phagocytosis Membrane Fusion Cellular Response To Osmotic Stress Positive Regulation Of Neutrophil Chemotaxis Regulation Of Calcium Ion Import Negative Regulation Of High Voltage-gated Calcium Channel Activity Negative Regulation Of Protein Polyubiquitination
Pathways		Smooth Muscle Contraction Neutrophil degranulation Dissolution of Fibrin Clot Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	Smooth Muscle Contraction Smooth Muscle Contraction
Drugs		Tenecteplase Artenimol
Diseases			Distal muscular dystrophies, including: Welander distal myopathy (WDM); Tibial muscular dystrophy (TMD); Nonaka distal myopathy with rimmed vacuoles (DMRV); Miyoshi myopathy (MM); Laing myopathy (MPD1); Distal nebulin myopathy (DNM); Distal desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Distal myotilinopathy (MFM3); Distal zaspopathy (MFM4); Distal myopathy 3 (MPD2, VCPDM) Dysferlinopathies, including: Miyoshi myopathy (MM); Limb-girdle muscular dystrophy (LGMD) 2B; Distal myopathy with anterior tibial onset (DMAT) Limb-girdle muscular dystrophy (LGMD)
GWAS		Asthma (age of onset) ( 31036433) Asthma (childhood onset) ( 31036433) Blood protein levels ( 30072576 28240269) Night sleep phenotypes ( 27126917) Type 2 diabetes ( 25102180)	Extremely high intelligence ( 29520040) General cognitive ability ( 29844566) Hip circumference adjusted for BMI ( 28552196) Nonalcoholic steatohepatitis-derived hepatocellular carcinoma ( 29385134) PR interval in Tripanosoma cruzi seropositivity ( 24324551) Protein quantitative trait loci ( 18464913) Urate levels in overweight individuals ( 25811787)
Interacting Genes		43 interacting genes: ACTA1 APOH APP CCDC32 CD99 CDC42 CEACAM1 CTSB CTSS DYSF GRB2 HMGA1 LGALS13 LYPLA1 MAP3K4 MYOC NOD2 OGDH PHB PLA1A PLA2G4A PLAT PLG POT1 PRKCA PRKCB PTEN RPS2 S100A10 S100A4 S100A6 SMN1 SNX17 SOS1 SRC STAT6 TENT2 TERF1 TERT TP53 TRPV5 YWHAQ ZBTB4	4 interacting genes: ANXA1 ANXA2 CAPN3 CAV3
Entrez ID		302	8291
HPRD ID		01061	04307
Ensembl ID		ENSG00000182718	ENSG00000135636
Uniprot IDs		A0A024R5Z7 P07355	O75923
PDB IDs		1W7B 1XJL 2HYU 2HYV 2HYW 4DRW 4FTG 4HRH 5LPU 5LPX 5LQ0 5LQ2 5N7D 5N7F 5N7G	4CAH 4CAI 4IHB 4IQH
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?